CLINICAL_TRIALS
trial_result
· 2016-11-02
Clinical Trial Update: A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia [Phase 2]
Summary
Phase 2 study of RO4917838 (Bitopertin) in patients with acute exacerbation of schizophrenia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED